Total Funding
58
38
Total FundingSeries A raised
Growth Score 58 in past quarter
-6 pts
Heat Score 38 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
25497
Jocasta Neuroscience is a biotech company that offers healthcare services.
- Albert Agro: Chief Executive OfficerPast Role: Sublimity Therapeutics, President and CEO
About the Company
Jocasta Neuroscience, Inc. is a preclinical-stage biotechnology company that specializes in developing therapies for cognitive impairment associated with neurodegenerative diseases, focusing on the biology of healthy aging and longevity. Jocasta is pioneering scientifically backed solutions for healthy cognitive aging, leveraging breakthrough
research in longevity biology. With deep expertise and exclusive IP, Jocasta stands at the forefront of developing novel therapeutics for dementia and related conditions.